Michael Link, MD
Clinical Cardiac Electrophysiology · Galloway, NJNPI 1477617710
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Atricure, Inc. at 47.7% of the total. Reporting peaked in 2019 at $37,935 and has fallen 70.2% since, to $11,301 in 2025. Among clinical cardiac electrophysiology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 388 payments — averaging $246.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$46K
- Boehringer Ingelheim$20K
- Lilly USA, LLC$18K
- Medtronic$5K
- Boston Scientific$3K
- Abbott$2K
- plus $3K from 30 others
Across 37 payments — averaging $945.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atricure, Inc.$35K
What the payments were for
- Consulting fees$40,17542%
- Speaking & faculty fees$30,11331%
- Travel & lodging$12,28713%
- Food & beverage$13,14914%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 90 | $45,625 |
| Boehringer Ingelheim | 36 | $19,638 |
| Lilly USA, LLC | 30 | $17,869 |
| Medtronic(2 entities) | 51 | $4,784 |
| Boston Scientific | 52 | $2,549 |
| Abbott | 27 | $2,238 |
| Impulse Dynamics (USA) Inc. | 8 | $650 |
| Biosense Webster, Inc. | 9 | $464 |
| Biotronik Inc. | 5 | $341 |
| Philips North America LLC | 12 | $299 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $206 |
| Pfizer | 8 | $169 |
| Novartis | 7 | $112 |
| Merck | 6 | $89 |
| Baxter Healthcare | 3 | $89 |
| Haemonetics Corporation | 1 | $89 |
| E.r. Squibb & Sons, L.L.C. | 4 | $56 |
| Altathera Pharmaceuticals LLC | 2 | $55 |
| Shockwave Medical, Inc | 4 | $55 |
| Amarin Pharma, Inc. | 2 | $44 |
| Sanofi | 2 | $39 |
| Heartflow, Inc. | 2 | $36 |
| Terumo Medical Corporation | 1 | $28 |
| Bayer | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| GSK | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Preventice Services, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$36,225
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$31,515
- EPI-SENSE GUIDED COAGULATION SYS$6,736
- ATRICLIP LAA EXCLUSION SYSTEM$3,007
- Arctic Front$1,362
- Watchman$1,292
- AVEIR$931
- OPTIMIZER$726
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$639
- SYNERGY ABLATION SYSTEM$615
- Micra$364
- WATCHMAN FLX$283
- ENSITE PRECISION$168
- Capsure$158
- ATRICURE SYNERGY ABLATION SYSTEM$145
- SelectSecure$135
- ATRICURE ATRICLIP LAA EXCLUSION$124
- Rivacor 7 DR-T$121
- Acticor 7 VR-T DX$121
- BioMonitor$121
How this compares
$95,730 in reported general payments places this provider in the 90th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 73 | $91,676 |
| EntrestoSacubitril/Valsartan | 24 | $35,987 |
| XareltoRivaroxaban | 19 | $26,264 |
| Dofetilide | 34 | $10,413 |
| Flecainide Acetate | 55 | $2,147 |
| Mexiletine Hcl | 18 | $1,727 |
| Metoprolol Succinate | 64 | $1,171 |
| SotalolSotalol Hcl | 48 | $1,152 |
| Amiodarone Hcl | 63 | $954 |
| Carvedilol | 40 | $415 |
| Rosuvastatin Calcium | 13 | $413 |
| Pantoprazole Sodium | 16 | $335 |
| Bisoprolol Fumarate | 15 | $297 |
| Furosemide | 40 | $281 |
| Losartan Potassium | 16 | $243 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $169 | $91,67673 claims |
| NovartisEntresto | $112 | $35,98724 claims |
| Johnson & JohnsonXarelto | $18 | $26,26419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Galloway
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Grant SimonsEnglewood$93K
- Jonathan SteinbergRidgewood$85K
- Gunjan ShuklaHackensack$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.